...

首页> 外文期刊>Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA >EVALUATION OF BONE METABOLISM MARKERS AND QOL IN PATIENTS WITH OSTEOPOROSIS AFTER TREATMENT WITH THE ANTI-RANKL ANTIBODY DENOSUMAB

【24h】

EVALUATION OF BONE METABOLISM MARKERS AND QOL IN PATIENTS WITH OSTEOPOROSIS AFTER TREATMENT WITH THE ANTI-RANKL ANTIBODY DENOSUMAB

机译：抗-RANKL抗体去甲丹参治疗骨质疏松症患者骨代谢指标和生活质量的评估

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA》 |2016年第1期|共2页
作者
Maeda T.; Hayashi S.; Miura Y.; Sakai Y.; Kuroda R.; Kurosaka M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类骨科学（运动系疾病、矫形外科学）;
关键词

相似文献

外文文献
中文文献
专利

1. EVALUATION OF BONE METABOLISM MARKERS AND QOL IN PATIENTS WITH OSTEOPOROSIS AFTER TREATMENT WITH THE ANTI-RANKL ANTIBODY DENOSUMAB [J] . Maeda T., Hayashi S., Miura Y., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2016,第Suppla1期

机译：抗-RANKL抗体去甲丹参治疗骨质疏松症患者骨代谢指标和生活质量的评估
2. AMG-162 Treatment of Osteoporosis Bone Cancer Therapy Treatment of Rheumatoid Arthritis Human Anti-RANKL Monoclonal Antibody [J] . J.A. Mcintyre, L Martin Drugs of the Future . 2005,第3期

机译：AMG-162骨质疏松症骨癌的治疗方法治疗类风湿关节炎人类抗RANKL单克隆抗体
3. CHANGES IN BONE MASS IN JAPANESE ELDERLY PATIENTS WITH OSTEOPOROSIS TREATED WITH ANTI-RANKL ANTIBODY FOLLOWING BONE FORMATION BY PTH FORMULATION [J] . Okada N., Kikuchi H., Itoh Y., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2016,第Suppla1期

机译：PTH配方治疗成骨后抗-RANKL抗体治疗的日本骨质疏松症老年患者骨质量的变化
4. Stoichiometry of soluble RANKL and anti-RANKL antibody (denosumab) complexes by native ESI TOF MS [C] . Pavel V. Bondarenko, Kelly K. Arthur, John P. Gabrielson, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：天然ESI TOF MS的可溶性RANKL和抗RANKL抗体（DENOSUMAB）复合物的化学计量
5. Effects of Some Chinese Herbs on Bone Metabolism - Osteoporosis and Bone Healing. [D] . Siu, Wing Sum. 2013

机译：一些中草药对骨代谢的影响-骨质疏松和骨愈合。
6. Serum bone alkaline phosphatase is a useful marker to evaluate lumbar bone mineral density in Japanese postmenopausal osteoporotic women during denosumab treatment [O] . Yukio Nakamura, Takako Suzuki, Hiroyuki Kato 2017

机译：血清骨碱性磷酸酶是评估denosumab治疗期间日本绝经后骨质疏松妇女腰椎骨矿物质密度的有用标志物
7. The mechanism of anti-RANKL antibody in the treatment of metabolic bone diseases including osteoporosis — possible applications of anti-RANKL antibody to the treatment of cancer patients [O] . Hisataka Yasuda 2019

机译：抗RANKL抗体在治疗代谢骨疾病的机制，包括骨质疏松症 - 抗rankl抗体对癌症患者治疗的可能应用

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号